HIV Pre-Exposure Prophylaxis Awareness among Individuals in Treatment for Opioid Use Disorder in the United States: A Cross-Sectional Study.

Mance E Buttram, Matthew S Ellis, José F Colón Burgos

Abstract read

In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mance E ButtramDepartment of Health, Human Performance, and Recreation, University of Arkansas, Fayetteville, AR, USA. mance@uark.edu.ORCID http://orcid.org/0000-0002-5001-7391

Matthew S EllisDepartment of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.

José F Colón BurgosDepartment of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, USA.

Funding

An Examination of Concomitant Non-Medical Use of Gabapentin and Opioids.R21DA056835 · NIDA · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI BUTTRAM, MANCE E. · 2022 to 2023

$412k

NIDA NIH HHS R21 DA056835

6 · The paper itself

Abstract

This study examined PrEP awareness among HIV-negative individuals in treatment for opioid use disorder (OUD; n = 179), and associations with demographic characteristics, sexual and injection behaviors, and treatment modalities. Overall, 48% of participants reported PrEP awareness. Bivariate logistic regression showed that, compared to others, individuals who were older, African American/Black, and in methadone treatment less frequently reported PrEP awareness (p≤.018), while those who reported sex with a person who injects drugs, inpatient/day treatment, and self-help group attendance more frequently reported PrEP awareness (p≤.041). Increased education and outreach to PrEP eligible individuals in methadone and other opioid treatment programs appears warranted.

Indexed as

Anti-HIV AgentsHealth Knowledge, Attitudes, PracticeHIV InfectionsOpioid-Related DisordersPre-Exposure ProphylaxisAdultCross-Sectional StudiesFemaleHumansLogistic ModelsMaleMethadoneMiddle AgedOpiate Substitution TreatmentSexual BehaviorUnited StatesAnti-HIV AgentsMethadoneHIVMethadoneOpioid treatmentOpioid use disorderPrEP awareness

Identifiers

PMID41843256

DOI10.1007/s10461-026-05057-x

PMCPMC13486035

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.